| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Entrada Therapeutics, Inc. (TRDA) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.96M | $21.22M | - | |
| 10% | 2.96M | $21.22M | - | |
| CEO | 526.0K | $3.77M | - | |
| 10% | 381.3K | $2.73M | - | |
| Pres | 216.3K | $1.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2022 | Kreher Nerissa54 | Chief Medical Officer | Sale+OE | 8,593 | $15.29 | $131,428.15 | -9.4% | -4.7% | +2.3% | |
| Sep 26, 2022 | Dowden Nathan J70 | Chief Operating Officer | Sell | 1,544 | $15.45 | $23,853.54 | -1.2% | +1.7% | +0.4% | |
| Sep 23, 2022 | Doshi Dipal62 | President And CEO | Sell | 4,425 | $15.10 | $66,837.83 | -1.0% | +1.8% | -4.4% | |
| Sep 23, 2022 | Kreher Nerissa54 | Chief Medical Officer | Sale+OE | 4,280 | $15.08 | $64,560.09 | -9.4% | +1.8% | -4.4% | |
| Sep 23, 2022 | Dowden Nathan J70 | Chief Operating Officer | Sell | 4,293 | $15.11 | $64,877.64 | -3.2% | +1.8% | -4.4% | |
| Sep 15, 2022 | Doshi Dipal62 | President And CEO | Sell | 200 | $15.04 | $3,008.00 | - | +38.9% | +15.2% | |
| Sep 15, 2022 | Dowden Nathan J70 | Chief Operating Officer | Sell | 100 | $15.01 | $1,501.00 | -0.1% | +38.9% | +15.2% | |
| Sep 15, 2022 | Kreher Nerissa54 | Chief Medical Officer | Sale+OE | 106 | $15.01 | $1,591.42 | -0.5% | +38.9% | +15.2% | |
| Sep 9, 2022 | Doshi Dipal62 | President And CEO | Sell | 1,788 | $15.12 | $27,039.50 | -0.4% | +40.8% | -4.5% | |
| Sep 9, 2022 | Dowden Nathan J70 | Chief Operating Officer | Sell | 1,777 | $15.11 | $26,845.13 | -1.3% | +40.8% | -4.5% |